Financial Daily from THE HINDU group of publications
Saturday, Apr 16, 2005
Financial Daily from THE HINDU group of publications Saturday, Apr 16, 2005 |
|
|
|
|
|
Corporate
-
Regulatory Bodies & Rulings FDA bans sale of Harpic; notice to No Marks soap Our Bureau
Mumbai , April 15 THE Maharashtra Food and Drug Administration (FDA) has prohibited the sale of Reckitt & Benckiser's popular disinfectant Harpic in the State. This follows a notice from the regulatory authority to the company, charging it with violating provisions of the Drugs and Cosmetics Act by not procuring the licence for manufacturing of the disinfectant, an FDA note said. Harpic is sold as a disinfectant and germs killer in the market, and, therefore, requires a licence for manufacturing it and the ingredients in the product have to conform to the provisions of the Drugs and Cosmetics Act, the note added. An FDA official said that the product is manufactured in Himachal Pradesh and the State's Drug Controller has also been "requested to take necessary action against the manufacturer for manufacturing the disinfectant without a drug licence," the note said. The company has been given 15 days to reply to the notice. The company officials were not available for comment. Further, the FDA has also issued a notice to the manufacturer of "No Marks" toilet soap and asked the manufacturer, Ozone Ayurvedic Company, to support its claims with documentation. "The company has been claiming in the advertisement that this is an `All Cure' dermatological soap with property to remove all types of blemishes on the skin such as acne, pimples, warts, toning of skin etc.," the FDA note said.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|